Talis Biomedical (TLIS) Return on Equity ROE from the second quarter 2024 to second quarter 2023 and annually, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Talis Biomedical Corporation  (NASDAQ: TLIS)

Talis Biomedical's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Talis Biomedical in the second quarter 2024?
Talis Biomedical Corporation recorded a cumulative net loss of $-51 million during 12 months ending in the second quarter 2024, resulting in a negative return on equity (ROE) of -79.73%.

Within the Laboratory Analytical Instruments industry 20 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2024 from 0 to 3402.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Equity Change -49.44 % -48.53 % -45.47 % -46.48 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -51 -57 -62 -75 -86
Return On Equity (TTM) -79.73 % -75.4 % -69.48 % -72.82 % -70.71 %
TLIS's Total Ranking # 3402 # 0 # 0 # 3355 # 3448
Equity (TTM) in Millions 49 57 69 82 96
Seq. Equity Change -14.22 % -17.99 % -15.25 % -15.19 % -12.67 %
Seq. Net Income Change - - - - -

Back to TLIS Management Effectiveness >> TLIS's 5 Years Annual ROE >> Compare TLIS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 21
Sector # 547
Overall # 3402

Return On Equity Statistics
High Average Low
-58.28 %
-68.89 %
-79.73 %
(Jun 30 2022)   (Jun 30 2024)





TLIS Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021

Total Equity in Millions 69 127 234 0 0
Y / Y Equity Change -45.47 % -45.83 % - - -
Net Income in Millions -62 -113 -192 0 0
Y / Y Net Income Change - - - - -
Return On Equity -89.71 % -89.17 % -82.07 % - -

Back to TLIS Management Effectiveness >> TLIS's 5 Years Annual ROE >> Compare TLIS ROE to its Competitors




More Return On Equity Ratios
Laboratory Analytical Instruments Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TLIS's' Return on Equity at Yahoo Finance
TLIS's Roe Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TLIS's Competitors
Subscribers only: Roe for Talis Biomedical's Suppliers
Subscribers only: Return On Equity for TLIS's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE

Date modified: 2026-08-29T17:43:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.